ACET Q3 2021 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+13.2% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$14M-399.8% margin

Net Income

-$14M-408.7% margin

EPS (Diluted)

$-7.04

QoQ Revenue Growth

-28.8%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$17M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$257M

Total Liabilities

$40M

Stockholders' Equity

$217M

Cash & Equivalents

$192M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+13.2%
Gross Profit	$3M	$3M	+13.2%
Operating Income	-$14M	-$14M	-0.4%
Net Income	-$14M	-$15M	+5.2%